Axogen, Inc. (AXGN) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $537.00K; Additional Paid in Capital, Common StockUSD $583.78M; Retained Earnings (Accumulated Deficit)USD $-328.06M; Stockholders' Equity Attributable to ParentUSD $256.26M.
- 2026-03-31: Common Stock, Value, IssuedUSD $532.00K; Additional Paid in Capital, Common StockUSD $570.82M; Retained Earnings (Accumulated Deficit)USD $-326.55M; Stockholders' Equity Attributable to ParentUSD $244.81M.
- 2025-12-31: Common Stock, Value, IssuedUSD $472.00K; Additional Paid in Capital, Common StockUSD $435.34M; Retained Earnings (Accumulated Deficit)USD $-306.96M; Stockholders' Equity Attributable to ParentUSD $128.85M.
- 2025-09-30: Common Stock, Value, IssuedUSD $461.00K; Additional Paid in Capital, Common StockUSD $414.15M; Retained Earnings (Accumulated Deficit)USD $-293.81M; Stockholders' Equity Attributable to ParentUSD $120.81M.
Axogen, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Retired, Par Value Method, Amount USD | Adjustments to Additional Paid in Capital, Warrant Issued USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $537.00K | $583.78M | $-328.06M | $256.26M | 3 month · $8.77M 6 month · $15.61M | (m) | (m) |
| 2026-03-31 | $532.00K | $570.82M | $-326.55M | $244.81M | 3 month · $6.84M | (m) | (m) |
| 2025-12-31 | $472.00K | $435.34M | $-306.96M | $128.85M | 12 month · $30.11M | (m) | (m) |
| 2025-09-30 | $461.00K | $414.15M | $-293.81M | $120.81M | 3 month · $5.42M 9 month · $13.50M | (m) | (m) |
| 2025-06-30 | $457.00K | $406.33M | $-294.51M | $112.28M | 3 month · $5.17M 6 month · $8.08M | (m) | (m) |
| 2025-03-31 | $455.00K | $400.00M | $-295.09M | $105.36M | 3 month · $2.91M | (m) | (m) |
| 2024-12-31 | $441.00K | $394.73M | $-291.26M | $103.91M | 12 month · $15.91M | (m) | (m) |
| 2024-09-30 | $440.00K | $390.68M | $-291.71M | $99.41M | 3 month · $5.00M 9 month · $12.83M | (m) | (m) |
| 2024-06-30 | $438.00K | $385.10M | $-289.85M | $95.69M | 3 month · $3.91M 6 month · $7.83M | (m) | (m) |
| 2024-03-31 | $437.00K | $380.65M | $-287.93M | $93.16M | 3 month · $3.92M | (m) | (m) |
| 2023-12-31 | $431.00K | $376.53M | $-281.30M | $95.67M | 12 month · $14.42M | (m) | (m) |
| 2023-09-30 | $430.00K | $374.78M | $-277.40M | $97.81M | 3 month · $4.75M 9 month · $13.09M | (m) | (m) |
| 2023-06-30 | $430.00K | $370.04M | $-273.31M | $97.15M | 3 month · $5.39M 6 month · $8.34M | (m) | (m) |
| 2023-03-31 | $428.00K | $363.74M | $-266.65M | $97.51M | 3 month · $2.95M | (m) | (m) |
| 2022-12-31 | $424.00K | $360.15M | $-259.58M | $101.00M | 12 month · $15.59M | (m) | (m) |
| 2022-09-30 | $423.00K | $355.19M | $-254.16M | $101.44M | 3 month · $3.85M 9 month · $11.44M | (m) | (m) |
| 2022-06-30 | $420.00K | $351.12M | $-249.85M | $101.69M | 3 month · $4.91M 6 month · $7.59M | (m) | (m) |
| 2022-03-31 | $420.00K | $345.54M | $-242.11M | $103.85M | 3 month · $2.68M | (m) | (m) |
| 2021-12-31 | $417.00K | $342.76M | $-230.63M | $112.55M | 12 month · $10.92M | (m) | (m) |
| 2021-09-30 | $415.00K | $340.21M | $-225.35M | $115.28M | 3 month · $2.91M 9 month · $9.41M | (m) | (m) |
| 2021-06-30 | $413.00K | $336.50M | $-218.21M | $118.70M | 3 month · $3.80M 6 month · $6.50M | (m) | (m) |
| 2021-03-31 | $408.00K | $329.60M | $-210.31M | $119.70M | 3 month · $2.69M | (m) | (m) |
| 2020-12-31 | $406.00K | $326.39M | $-203.65M | $123.15M | 12 month · $8.47M | (m) | (m) |
| 2020-09-30 | $401.00K | $318.95M | $-197.64M | $121.71M | 3 month · $2.95M 9 month · $5.72M | (m) | (m) |
| 2020-06-30 | $400.00K | $315.52M | $-196.16M | $119.76M | 3 month · $2.22M 6 month · $2.78M | (m) | (m) |
| 2020-03-31 | $397.00K | $311.85M | $-188.05M | $124.19M | 3 month · $556.00K | (m) | (m) |
| 2019-12-31 | $396.00K | $311.62M | $-179.86M | $132.15M | 12 month · $10.30M | (m) | (m) |
| 2019-09-30 | $395.00K | $307.84M | $-172.82M | $135.41M | 3 month · $2.40M 9 month · $7.38M | (m) | (m) |
| 2019-06-30 | $393.00K | $304.82M | $-167.25M | $137.96M | 3 month · $2.67M 6 month · $4.99M | (m) | (m) |
| 2019-03-31 | $391.00K | $300.58M | $-160.23M | $140.74M | 3 month · $2.31M | (m) | (m) |
| 2018-12-31 | $389.00K | $297.32M | $-150.73M | $146.98M | 12 month · $7.61M | (m) | (m) |
| 2018-09-30 | $386.72K | $294.59M | $-145.50M | $149.48M | 3 month · $2.21M 9 month · $5.98M | (m) | (m) |
| 2018-06-30 | $383.11K | $291.52M | $-141.40M | $150.50M | 3 month · $2.04M 6 month · $3.77M | (m) | (m) |
| 2018-03-31 | $346.69K | $155.31M | $-133.97M | $21.69M | 3 month · $1.73M | (m) | (m) |
| 2017-12-31 | $343.00K | $153.17M | $-128.33M | $25.18M | 12 month · $3.61M | (m) | (m) |
| 2017-09-30 | $333.94K | $136.05M | $-125.83M | $10.55M | (m) | (m) | (m) |
| 2017-06-30 | $331.85K | $134.68M | $-123.71M | $11.31M | (m) | (m) | (m) |
| 2017-03-31 | $330.64K | $133.44M | $-121.65M | $12.12M | (m) | (m) | (m) |
| 2016-12-31 | $330.09K | $132.47M | $-117.88M | $14.92M | 12 month · $1.39M | (m) | (m) |
| 2016-09-30 | $302.09K | $113.06M | $-112.26M | $1.10M | (m) | (m) | (m) |
| 2016-06-30 | $301.28K | $112.44M | $-109.95M | $2.79M | (m) | (m) | (m) |
| 2016-03-31 | $300.36K | $111.69M | $-107.15M | $4.84M | (m) | (m) | (m) |
| 2015-12-31 | $299.85K | $111.37M | $-103.47M | $8.20M | 12 month · $1.32M | (m) | (m) |
| 2015-09-30 | $298.44K | $110.74M | $-99.86M | $11.18M | (m) | (m) | (m) |
| 2015-06-30 | $249.32K | $93.10M | $-96.88M | $-3.53M | (m) | (m) | (m) |
| 2015-03-31 | $249.26K | $92.76M | $-93.69M | $-680.50K | (m) | (m) | (m) |
| 2014-12-31 | $194.89K | $78.68M | $-90.12M | $-11.25M | 12 month · $956.45K | (m) | (m) |
| 2014-09-30 | $174.66K | $73.26M | $-83.62M | $-10.19M | (m) | (m) | (m) |
| 2014-06-30 | $174.66K | $73.04M | $-80.39M | $-7.18M | (m) | (m) | (m) |
| 2014-03-31 | $174.46K | $72.78M | $-76.65M | $-3.69M | (m) | (m) | (m) |
| 2013-12-31 | $173.40K | $72.37M | $-72.41M | $136.63K | 12 month · $671.89K | (m) | (m) |
| 2013-09-30 | $173.39K | $72.24M | $-68.30M | $4.11M | (m) | (m) | (m) |
| 2013-06-30 | $111.40K | $55.33M | $-64.74M | $-9.30M | (m) | (m) | (m) |
| 2013-03-31 | $111.28K | $55.17M | $-61.29M | $-6.01M | (m) | (m) | (m) |
| 2012-12-31 | $111.23K | $54.91M | $-57.85M | $-2.83M | 12 month · $495.08K | (m) | (m) |
| 2012-09-30 | $111.05K | $54.90M | $-53.81M | $1.21M | (m) | 9 month · $21.38K | (m) |
| 2012-06-30 | $111.04K | $54.73M | $-51.57M | $3.27M | (m) | 6 month · $21.38K | (m) |
| 2012-03-31 | $110.62K | $54.55M | $-50.54M | $4.12M | (m) | (m) | (m) |
| 2011-12-31 | $110.62K | $54.39M | $-48.43M | $6.07M | 12 month · $250.04K | (m) | 12 month · $173.74K |
| 2011-09-30 | $109.50K | $54.14M | $-46.29M | $7.96M | (m) | (m) | (m) |
| 2011-06-30 | $43.05K | $13.30M | $-1.79M | $11.55M | (m) | (m) | (m) |
| 2010-12-31 | $12.06K | $9.93M | $-38.18M | $-27.11M | 12 month · $187.46K | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | $-28.64M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |